LERCANIDIPINE IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/10300

Full metadata record

DC Field	Value	Language
dc.contributor.author	Shoalimova Z.M., Maxmudova M.S.	-
dc.date.accessioned	2024-01-16T07:50:01Z	-
dc.date.available	2024-01-16T07:50:01Z	-
dc.date.issued	2023	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/10300	-
dc.description.abstract	Thus, in patients with isolated middleaged and elderly systolic hypertension, antihypertensive monotherapy with lercanidipine has a comparable antihypertensive effect, leads to normalization of the daily blood pressure profile with the achievement of the target level of systolic blood pressure in 73.3 and 75% of patients, respectively.	en_US
dc.language.iso	en	en_US
dc.publisher	СБОРНИК ТЕЗИСОВ XIII МЕЖДУНАРОДНОГО КОНГРЕССА «КАРДИОЛОГИЯ НА ПЕРЕКРЕСТКЕ НАУК»	en_US
dc.subject	systolic hypertension, antihypertensive monotherapy, lercanidipine	en_US
dc.title	LERCANIDIPINE IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION	en_US
dc.type	Thesis	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
Shoalimova Z.M., Maxmudova M.S. 2.pdf	LERCANIDIPINE IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION	2.33 MB	Adobe PDF	View/Open

DSpace JSPUI